These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16426986)

  • 1. Towards individualised multiple sclerosis treatment.
    Holmøy T; Hestvik AL; Vartdal F
    Lancet Neurol; 2006 Feb; 5(2):111-2. PubMed ID: 16426986
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of hemosorption in disseminated sclerosis].
    Golovkin VI; Pershin VN; Tulenko AG
    Vrach Delo; 1986 Feb; (2):84-6. PubMed ID: 3486528
    [No Abstract]   [Full Text] [Related]  

  • 3. [Multiple sclerosis].
    Tanosaki M; Matsunaga M
    Nihon Rinsho; 2004 May; 62 Suppl 5():586-9. PubMed ID: 15197989
    [No Abstract]   [Full Text] [Related]  

  • 4. Favourable response to plasma exchange in tumefactive CNS demyelination with delayed B-cell response.
    Seifert CL; Wegner C; Sprenger T; Weber MS; Brück W; Hemmer B; Sellner J
    Mult Scler; 2012 Jul; 18(7):1045-9. PubMed ID: 22086900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic aspects of multiple sclerosis.
    Taylor RS
    Phys Med Rehabil Clin N Am; 1998 Aug; 9(3):525-36, v. PubMed ID: 9894106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunology of multiple sclerosis.
    Oger J; Roos R; Antel JP
    Neurol Clin; 1983 Aug; 1(3):655-79. PubMed ID: 6209537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunology of multiple sclerosis. Recent data and therapeutic perspectives].
    Tourbah A; Fontaine B; Lyon-Caen O
    Rev Neurol (Paris); 1993; 149(6-7):373-84. PubMed ID: 8303156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [T and B lymphocytes in multiple sclerosis].
    Argentiero V; Tavolato B; Bertolissi M; Gentile B
    Acta Neurol (Napoli); 1977; 32(4):470-2. PubMed ID: 303044
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of B cells in multiple sclerosis: rationale for B-cell-targeted therapies.
    Racke MK
    Curr Opin Neurol; 2008 Apr; 21 Suppl 1():S9-S18. PubMed ID: 18388801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New concepts in the immunopathogenesis of multiple sclerosis.
    Hemmer B; Archelos JJ; Hartung HP
    Nat Rev Neurosci; 2002 Apr; 3(4):291-301. PubMed ID: 11967559
    [No Abstract]   [Full Text] [Related]  

  • 11. Mitogen-induced plasma cell differentiation in patients with multiple sclerosis.
    Levitt D; Griffin NB; Egan ML
    J Immunol; 1980 May; 124(5):2117-21. PubMed ID: 6965966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis: from basic immunopathology to immune intervention.
    Miller A; Galboiz Y
    Clin Neurol Neurosurg; 2002 Jul; 104(3):172-6. PubMed ID: 12127650
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rapid modification of the symptomatology of progressive forms of multiple sclerosis by plasma exchange].
    Trouillas P; Neuschwander P; Trémisi JP
    Rev Neurol (Paris); 1986; 142(8-9):689-95. PubMed ID: 3809855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controversy in treatment of multiple sclerosis.
    Hobbs JR
    Lancet; 1991 Jul; 338(8760):193-4. PubMed ID: 1677098
    [No Abstract]   [Full Text] [Related]  

  • 15. [The dynamics of immunological indicators in the treatment of patients with multiple sclerosis with prednisolone combined with plasmapheresis].
    Neretin VIa; Gannushkina IV; Zhirnova IG; Sapfirova VA; Kir'iakov VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(2):17-21. PubMed ID: 3259769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperation of B cells and T cells in the pathogenesis of multiple sclerosis.
    Weber MS; Hemmer B
    Results Probl Cell Differ; 2010; 51():115-26. PubMed ID: 19582406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of autoimmunity in multiple sclerosis].
    Chabas D; Liblau R
    Pathol Biol (Paris); 2000 Feb; 48(1):25-46. PubMed ID: 10729910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of a factor from multiple sclerosis serum on isolated T and B lymphocytes.
    Armentrout SA; Sweet PM; Galant SP
    J Clin Lab Immunol; 1981 May; 5(3):133-6. PubMed ID: 6972451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T and B lymphocytes in multiple sclerosis.
    Lisak RP; Levinson AI; Zweiman B; Abdou NI
    Clin Exp Immunol; 1975 Oct; 22(1):30-4. PubMed ID: 1082395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytokines slow down the progression of MS. Successful animal experiments with a vaccine].
    Orn P
    Lakartidningen; 1996 Feb; 93(7):573-5. PubMed ID: 8642918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.